Navigation Links
Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
Date:4/9/2008

oking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended December 31, 2007. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved.

Poniard and Poniard Pharmaceuticals are trademarks of Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
2. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
3. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
4. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
7. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
8. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
11. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Delays in the launch and ... down the decision-making process, resulting in missed opportunities ... for biopharmaceutical companies to develop a tactical approach ... quicker and more meaningful insights. ... nearly three-quarters of benchmarked study participants use review ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Originally discovered ... as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory ... by Senju Pharmaceutical Co., Ltd under the trade ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... 2011 The Consumer Healthcare Products Association (CHPA) today ... Mitch Daniels signing into law a bill that requires ... pseudoephedrine (PSE) in real time allowing retailers and pharmacists ... legal limit: "Both the executive and legislative ...
... Calif., May 13, 2011 Amgen (NASDAQ: AMGN ... Urological Association (AUA) Conference on Tuesday, May 17 at 12:00 ... and a clinical investigator will participate at the meeting to ... audio of the conference call will be simultaneously broadcast over ...
Cached Medicine Technology:Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference 2
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 ... contains 15 seconds of unique footage that users can shrink and stretch in the ... and more. Users can customize color, brightness, scale, speed, range, and flare attributes with ...
(Date:8/29/2015)... , ... August 29, 2015 , ... The popular television ... Earl Jones, recently announced that it will be devoting an entire short segment to ... millions of people around the globe on a daily basis, but recent advancements in ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
(Date:8/28/2015)... ... 28, 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth ... are applying for, they are unable to pass the initial drug test and therefore ... policies in order to be able to hire long-term, skilled talent. (1) Will Wesch, ...
Breaking Medicine News(10 mins):Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... An influential report on,cancer prevention provides new ... say doctors with the Physicians Committee for,Responsible Medicine ... American,Institute for Cancer Research (AICR). A comprehensive review ... research showing that meat and,alcohol consumption increase one,s ...
... Memo to Researchers: Correlation Is Not The Same ... the American,Institute for Cancer Research (AICR) released a ... of Cancer." Accompanying the report,was a recommendation that ... In response, David Martosko, the Director of Research ...
... HAE: TSX, MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - ... webcast of,its presentation at the Acumen BioFin Rodman ... 2007 at 11:30 a.m. at the New York,Palace ... will webcast the audio portion of the presentation ...
... To Help Ensure ... Needs Are Met, INDIANAPOLIS, ... to victims of the southern California wildfires. As,the most immediate threat to ... take root, impacting all,residents, but especially those suffering from chronic diseases. ...
... Expo, Who: Lifespring Health ( http://www.lifespringhealth.com ) offers free ... afford a healthy lifestyle and will be sponsoring ... The run is set in San Jose and is a ... Saturday 11/3 from 10 am - 4 pm ...
... - Live Webcast on Tuesday, November 6 at 8:50 ... Somanetics Corporation,(Nasdaq: SMTS ) announced that William Iacona, ... Rodman & Renshaw 9th Annual,Healthcare Conference being held November ... York. Mr. Iacona,s presentation, scheduled for 8:50 a.m. ET ...
Cached Medicine News:Health News:Just-Released Cancer Report Provides New Ammunition for Farm Bill Reform Effort 2Health News:Consumers Should Demand Evidence, Not Guesswork, On Meat-Cancer Links 2Health News:Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec 2Health News:WellPoint Provides Support and Resources to Most Vulnerable California Residents 2Health News:WellPoint Provides Support and Resources to Most Vulnerable California Residents 3Health News:Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: